Related Experiment Video
Updated: Sep 16, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
A Frequentist Approach Using Weighted Estimating Equations for Survival Analysis of Randomized Controlled Trial With
Ryo Sawamoto1, Koji Oba2, Yutaka Matsuyama3
1Biometrics Department, Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.
Abstract:
Clinical trials using a hybrid control, which integrates a randomized control with external control data, may be one solution to facilitate clinical development where traditional randomized controlled trials are challenging. Despite its attractive features, systematic differences between controls can introduce bias in treatment effect estimation and inflate Type I error. Although propensity score methods may be used to address systematic differences from measured covariate imbalance, potential differences from unmeasured or unknown factors may still arise despite careful consideration. In such cases, dynamic borrowing methods have been proposed to account for potential differences between randomized and external control data and discount the contribution of external control data when needed. Conventional methods, however, often rely on Bayesian approaches, requiring proper specification of the likelihood. This is particularly challenging for survival analysis using proportional hazards model due to specification of the baseline hazard function. To address these challenges, we propose to utilize the weighted partial likelihood score equation where external control patients are weighted by the inverse probability of the propensity score and an additional discounting weight, adjusting the contribution of external control data according to its similarity to randomized control data. A new variance estimator based on stacked estimating equations is proposed to incorporate the uncertainty in estimating discounting weights. Operating characteristics of the proposed method are studied via extensive simulation. The proposed method yields reduced bias in treatment effect estimation and Type I error while improving statistical power in either scenarios where measured or unmeasured confounders exist.
Related Concept Videos
Kaplan-Meier Approach
Comparing the Survival Analysis of Two or More Groups
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Assumptions of Survival Analysis
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Censoring Survival Data
